San Diego, CA, United States of America

Jillian Frances Evans

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 130(Granted Patents)


Location History:

  • Carlsbad, CA (US) (2011)
  • San Diego, CA (US) (2008 - 2023)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jillian Frances Evans

Introduction

Jillian Frances Evans, based in San Diego, CA, is a prolific inventor with a remarkable portfolio of eight patents. Her work focuses on advancements in the medical field, particularly in the areas of targets for drug development and innovative therapies.

Latest Patents

Two of her latest patents exemplify her groundbreaking contributions:

1. **Uses of a Lysyl Oxidase-Like 2 Inhibitor** - This patent describes the use of a LOXL2 inhibitor in the treatment or prevention of various conditions, diseases, or disorders associated with LOXL2 activity.

2. **Autotaxin Inhibitors and Uses Thereof** - This patent outlines methods and compositions for treating conditions linked to autotaxin activity, including the use of at least one autotaxin inhibitor compound.

Career Highlights

Throughout her career, Jillian has worked with esteemed organizations such as Panmira Pharmaceuticals and Amira Pharmaceuticals. Her experience in these companies has helped foster her innovative spirit and drive for research-based solutions to complex medical issues.

Collaborations

Jillian has collaborated with notable colleagues including John Howard Hutchinson and Petpiboon Peppi Prasit. These partnerships have played a vital role in enhancing her research and expanding the impact of her inventions.

Conclusion

With her eight patents and a commitment to advancing medical science, Jillian Frances Evans stands out in the realm of innovation. Her ongoing contributions significantly shape the landscape of therapeutic research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…